Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma-Cell Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00033332
What this trial is testing

Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT06508463
What this trial is testing

Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T Cell LymphomaRelapsed Peripheral T-Cell LymphomaPeripheral T-Cell Lymphoma, Not Otherwise Specified+4 more
Mayo Clinic 21
Not applicableLooking for participantsNCT05283993
What this trial is testing

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Who this might be right for
Multiple MyelomaAmyloidosisCryoglobulinemia+9 more
Peking University First Hospital 2,000
Testing effectiveness (Phase 2)Ended earlyNCT00437034
What this trial is testing

Aflibercept for Relapsed Multiple Myeloma

Who this might be right for
Stage II Multiple MyelomaStage III Multiple Myeloma
National Cancer Institute (NCI) 6
Large-scale testing (Phase 3)Looking for participantsNCT07413809
What this trial is testing

Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen

Who this might be right for
Multiple Myeloma
The Affiliated People's Hospital of Ningbo University 92
Early research (Phase 1)Study completedNCT01580371
What this trial is testing

Safety and Pharmacokinetic Profile of CKD-581

Who this might be right for
LymphomaMultiple Myeloma
Chong Kun Dang Pharmaceutical 39
Not applicableStudy completedNCT04014764
What this trial is testing

Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy

Who this might be right for
Acute Myelogenous LeukemiaMultiple MyelomaMyelodysplastic Syndromes+4 more
Notable Labs 119
Testing effectiveness (Phase 2)Study completedNCT01177371
What this trial is testing

High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+70 more
Case Comprehensive Cancer Center 13
Large-scale testing (Phase 3)Active Not RecruitingNCT03539744
What this trial is testing

A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.

Who this might be right for
Multiple Myeloma
AbbVie 265
Early research (Phase 1)Ended earlyNCT02998047
What this trial is testing

A Phase I Study of Lintuzumab-Ac225 in Patients With Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple Myeloma
Actinium Pharmaceuticals 2
Testing effectiveness (Phase 2)Study completedNCT01058434
What this trial is testing

Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Novartis Pharmaceuticals 43
Not applicableLooking for participantsNCT05737732
What this trial is testing

The Ambient Light Multiple Myeloma Study

Who this might be right for
Multiple Myeloma
Icahn School of Medicine at Mount Sinai 200
Testing effectiveness (Phase 2)Study completedNCT02086552
What this trial is testing

Sonidegib and Lenalidomide After Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Mayo Clinic 28
Testing effectiveness (Phase 2)WithdrawnNCT01445587
What this trial is testing

GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma

Who this might be right for
Cancer
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT01090921
What this trial is testing

Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Boston VA Research Institute, Inc. 50
Testing effectiveness (Phase 2)Looking for participantsNCT05979363
What this trial is testing

Bortezomib, Lenalidomide and Dexamethasone (VRd)-Based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With Primary Plasma Cell Leukemia

Who this might be right for
Plasma Cell Leukemia
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Ended earlyNCT02863991
What this trial is testing

Oral ONC201 in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Jazz Pharmaceuticals 17
Early research (Phase 1)UnknownNCT03836690
What this trial is testing

Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation

Who this might be right for
LymphomaLeukemiaMyeloma+4 more
University College, London 18
Not applicableEnded earlyNCT00897910
What this trial is testing

Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Barbara Ann Karmanos Cancer Institute 6
Testing effectiveness (Phase 2)Study completedNCT00533923
What this trial is testing

Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders

Who this might be right for
AMLALLCLL+6 more
Beth Israel Deaconess Medical Center 25
Next Page